Daily FNArena News - Small Caps

Recent research on Macquarie Technology shows a strong near-term cloud demand outlook and a significant growth profile in coming years

New research identifies Alcidion Group is attaining scale and becoming profitable at an opportune time for healthcare technology demand

New research on Capricorn Metals anticipates growth potential along with consistent profits and increasing dividends over time

Tim Boreham takes a look at Lumos Diagnostics, which specialises in rapid point-of-care tests to help healthcare professionals diagnose and manage medical conditions more accurately

While Sigma Healthcare is a clear winner in gaining the Chemist Warehouse contract from Ebos, the damage is not that significant for Ebos in broker views

PeopleIN’s strategic review failed to realise extra value, nor was a sale forthcoming, but brokers back the company’s decision to stay the course

A positive trial result could put a rocket on shares in Dimerix, reports Tim Boreham, but investors won’t know the answer until early 2024

Recent research on Dicker Data notes an improving distribution capability and potential synergies from recent acquisitions

Tim Boreham reports cancer treatment biotech Chimeric has struggled, but may yet have a sting in its tail

Brokers remain enthusiastic on the outlook for Life360 following first quarter results